P Gisondi
Overview
Explore the profile of P Gisondi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
2003
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burlando M, Megna M, Caldarola G, Bernardini N, Giofre C, Gisondi P, et al.
Eur Rev Med Pharmacol Sci
. 2024 Oct;
28(18):4298-4301.
PMID: 39359201
Objective: The use of biologic agents, mainly tumor necrosis factor (TNF)-α and interleukin (IL)-17A inhibitors, was associated with cutaneous side effects, but the factors associated with eczematous reactions occurring during...
2.
Piraccini B, Pampaloni F, Cedirian S, Quadrelli F, Bruni F, Rapparini L, et al.
J Eur Acad Dermatol Venereol
. 2024 Sep;
PMID: 39247945
Background: Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows and eyelashes, for which treatments are limited. Baricitinib, an oral inhibitor of Janus kinases...
3.
Orsini D, Megna M, Assorgi C, Balato A, Balestri R, Bernardini N, et al.
J Dermatolog Treat
. 2024 Aug;
35(1):2393376.
PMID: 39164008
The aim of this multicenter observational study is to report data from real world on the use of bimekizumab in patients aged ≥ 65 years with moderate-to-severe plaque psoriasis. Elderly...
4.
Bellinato F, Gisondi P, Dattola A, Richetta A, Costanzo A, Valenti M, et al.
J Eur Acad Dermatol Venereol
. 2023 Dec;
38(5):e437-e439.
PMID: 38084869
No abstract available.
5.
Sacchelli L, Filippi F, Balato A, Balestri R, Bellinato F, Bernardini N, et al.
J Eur Acad Dermatol Venereol
. 2023 Dec;
38(3):e215-e218.
PMID: 38059550
No abstract available.
6.
Medori M, Gisondi P, Bellinato F, Bonetti G, Micheletti C, Donato K, et al.
Clin Ter
. 2023 Nov;
174(Suppl 2(6)):236-242.
PMID: 37994770
Background: Genodermatoses are rare heterogeneous genetic skin diseases with multiorgan involvement. They severely impair an individual's well-being and can also lead to early death. Methods: During the progress of this...
7.
Medori M, Donato K, Dhuli K, Maltese P, Tanzi B, Tezzele S, et al.
Clin Ter
. 2023 Nov;
174(Suppl 2(6)):29-36.
PMID: 37994746
Background: This article provides an overview of the application of omics sciences in melanoma research. The name omics sciences refers to the large-scale analysis of biological molecules like DNA, RNA,...
8.
Magnano M, Balestri R, Gisondi P, Bardazzi F, Di Lernia V, Ioris T, et al.
J Eur Acad Dermatol Venereol
. 2023 Nov;
38(4):e331-e334.
PMID: 37909105
No abstract available.
9.
Tirelli F, Giraudo C, Soliani M, Calabrese F, Martini G, Gisondi P, et al.
Pediatr Rheumatol Online J
. 2023 Oct;
21(1):125.
PMID: 37848914
Background: Connective tissue nevi (CTN) are congenital hamartomas caused by excessive proliferation of dermis components. In children, CTN can mimic juvenile localized scleroderma (JLS), an immune mediated skin disorder that...
10.
Gisondi P, Maurelli M, Costanzo A, Esposito M, Girolomoni G
Dermatol Ther (Heidelb)
. 2022 Nov;
13(1):7-12.
PMID: 36355314
Introduction: Dupilumab is an interleukin-4 (IL-4) receptor alpha antagonist indicated for the treatment of moderate-to-severe atopic dermatitis (AD), which could be associated with atopic and non-atopic comorbidities for which concomitant...